idahen.org

Genzyme Corporation Moves Closer to Acquiring Bioenvision, Inc.
MSN MoneyCentral - Genzyme’s commitment to innovation continues today with a substantial development program focused on these fields, as well as immune disease, infectious disease, and other areas of unmet medical need. Important Information Regarding the Tender

This entry was posted on Saturday, June 30th, 2007 at 1:05 pm and is filed under Latest News. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.